1-5 of 5
Abdellatif Amri
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A New Form Of Therapeutic Resistance: Drug Glucuronidation Regulated By The Sonic Hedgehog Factor Gli1

Hiba A Zahreddine, Biljana Culjkovic-Kraljacic, PhD, Sarit Assouline, MD, Abdellatif Amri, Patrick Gendron, M.Sc., Andrea A. Romeo, PhD, Stephen Morris, PhD, James Jaquith, PhD, Gregory Cormack, Eftihia Cocolakis, PhD, Julie Bergeron, MD, Leandro Cerchietti, MD, Brian Leber, MD, Wilson H. Miller, Jr., MD, PhD, Katherine LB. Borden, PhD
Journal: Blood
Blood (2013) 122 (21): 821.
https://doi.org/10.1182/blood.V122.21.821.821
Published: 2013
Journal Articles

A Phase I Combination Study of Ribavirin and Low Dose Cytarabine Arabinoside (ara-C) in M4/M5 Acute Myeloid Leukemia (AML) and AML with High eIF4E,

Sarit Assouline, MD, Biljana Kraljacic-Culjkovic, PhD, Eftihia Cocolakis, PhD, Abdellatif Amri, Julie Bergeron, MD, Rahima Jamal, MD, Wilson H. Miller, Jr., MD, PhD, Katherine LB Borden, PhD
Journal: Blood
Blood (2011) 118 (21): 3606.
https://doi.org/10.1182/blood.V118.21.3606.3606
Published: 2011
Journal Articles

The Eukaryotic Translation Initiation Factor eIF4E, a Recently Identified Therapeutic Target In AML, Is a Direct Transcriptional Target of NFkB

Fadi Hariri, Meztli Arguello, PhD, Biljana Culjkovic, PhD, Abdellatif Amri, Katherine Borden, PhD
Journal: Blood
Blood (2010) 116 (21): 3146.
https://doi.org/10.1182/blood.V116.21.3146.3146
Published: 2010
Journal Articles

Targeting the Oncogene eIF4E with Ribavirin: A Novel Therapeutic Avenue in Acute Myeloid Leukemia.

Sarit E. Assouline, MD, Eftihia Cocolakis, PhD, Caroline Rousseau, PhD, Biljana Culjkovic, PhD, Nathalie Beslu, PhD, Abdellatif Amri, Stephen N. Caplan, MD, Brian Leber, MD, Denis-Claude Roy, MD, Katherine L. B. Borden, PhD, Wilson H. Miller, Jr., MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2085.
https://doi.org/10.1182/blood.V114.22.2085.2085
Published: 2009
Journal Articles

Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin

Brief Report
Sarit Assouline, Biljana Culjkovic, Eftihia Cocolakis, Caroline Rousseau, Nathalie Beslu, Abdellatif Amri, Stephen Caplan, Brian Leber, Denis-Claude Roy, Wilson H. Miller, Jr, Katherine L. B. Borden
Journal: Blood
Blood (2009) 114 (2): 257–260.
https://doi.org/10.1182/blood-2009-02-205153
Published: 2009
Includes: Supplemental data